03:10 AM EDT, 10/09/2025 (MT Newswires) -- Eric Venker, President & Immunovant Chief Executive Officer, on October 06, 2025, sold 665,159 shares in Roivant Sciences ( ROIV ) for $10,781,813. Following the Form 4 filing with the SEC, Venker has control over a total of 1,504,959 common shares of the company, with 1,504,959 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1635088/000114036125037740/xslF345X05/form4.xml